Why NAD⁺ Matters Now – Practical Insights for Your Practice
Posted on: April 1, 2026
Posted on:
Why NAD⁺ Matters Now – Practical Insights for Your Practice
The IV Market Boomed in 2025 – Here’s How NAD⁺ Can Help You Capitalise
Intravenous (IV) nutrient therapies such as vitamin drips, B-complex infusions, and hydration therapy have become increasingly popular in both medical and wellness settings. These treatments are widely used to support energy levels, immune function, and recovery by delivering nutrients directly into the bloodstream, bypassing gastrointestinal absorption.
For many patients, these therapies can provide noticeable short-term benefits, particularly in cases of fatigue, dehydration, or nutrient depletion. However, as demand grows for more targeted, cellular-level interventions, attention has shifted toward more advanced therapies.
The UK IV wellness market (vitamins, energy, beauty, hydration) made £150 million in 2025.
NAD⁺ IV therapy represents this next evolution moving beyond general nutrient replenishment toward supporting the fundamental biological processes that underpin energy production, cellular repair, and healthy ageing.
The UK IV wellness market is projected to grow to £315 million by 2033, at around 10% annual growth. The market in 2025 made £150 million alone.
What Is NAD+ ?
NAD⁺ (nicotinamide adenine dinucleotide) is an essential coenzyme present in all living cells. It plays a central role in:
- Mitochondrial ATP production (oxidative phosphorylation)
- Redox reactions
- DNA repair (via PARPs)
- Cellular stress responses
- Sirtuin activation and metabolic regulation
NAD⁺ levels naturally decline with age and metabolic stress, which may contribute to reduced energy, impaired cellular repair, and features of biological ageing.
IV administration bypasses the variability of oral absorption, allowing for controlled dosing under appropriate clinical supervision.
Adding L-Glutathione
L-glutathione, a key intracellular antioxidant, is sometimes administered alongside NAD⁺ to support redox balance and recovery.
Again, this is supportive therapy, not curative medicine.
Clinical and Strategic Benefits for Your Practice:
When delivered within a regulated medical framework, NAD⁺ IV therapy can offer both clinical and operational advantages:
- Patient retention: Keeps patients seeking optimisation therapies within a medically supervised environment
- Service expansion: Supports preventative, longevity, and metabolic health programmes
- Practice differentiation: Positions the clinic within a growing market focused on proactive health optimisation
- Revenue growth: Provides a structured, clinically governed additional income stream
When integrated responsibly, it enables clinicians to meet increasing patient demand while maintaining safety, transparency, and professional standards.
Which of your patients can benefit from NAD+ the most?
Patients who may benefit most from NAD⁺ IV therapy are those experiencing reduced energy, increased physiological stress, or early signs of age-related decline, particularly where mitochondrial function and cellular repair may be impacted. In clinical practice, this often includes:
- Patients with persistent fatigue or burnout
- Individuals with high-demand lifestyles and poor recovery
- Those experiencing reduced cognitive clarity or mental performance
- Patients seeking proactive support for healthy ageing and longevity
As with any intervention, NAD⁺ IV therapy is best positioned as a supportive strategy within a well-governed clinical framework, with appropriate patient selection and expectation management.
Ready to Integrate NAD⁺ IV Therapy Into Your Practice?
The NAD⁺ IV Course at DrBKTI provides clinicians with the knowledge, safety protocols, governance frameworks, and practical guidance required to introduce NAD⁺ therapy confidently and ethically.
Enrol today to learn how to deliver NAD⁺ IV therapy safely and strategically within your clinic.
